Completed
Analysis of the Association of Products for the Treatment of Cervical Dentin Hypersensitivity
Led by Federal University of Uberlandia · Updated on 2016-10-14
140
Participants Needed
1
Research Sites
25 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of this study is through a randomized clinical trial, double blind, splith-mouth, evaluate the various types of protocols and clinical efficacy in the reduction or even elimination of dentinal hypersensitivity by the agents Desensibilize KF - FGM Dental Products, Clinpro - 3M Company, Minnesota - USA, Photon Laser III - DMC, Brazil, Desensibilize KF and laser, Desensibilize KF and Clinpro, laser and Clinpro and the association of all products. Data will be collected, tabulated and submitted to statistical analysis.
CONDITIONS
Brief Title
Assessment of Different Protocols for Cervical Dentin Hypersensitivity Treatment
Who Can Participate
Eligibility Criteria
Inclusion Criteria:
- presence of dentin exposure lesions with clinical diagnosis of moderate or severe tooth sensitivity
- good oral hygiene.
Exclusion Criteria:
- cavities,
- presence of periodontal disease and or parafunctional habits,
- cracks or enamel fractures,
- extensive or unsatisfactory restorations,
- recent restorations involving the labial surface,
- dentures,
- orthodontics.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here